"Hyaluronan Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Acidic sulfated integral membrane glycoproteins expressed in several alternatively spliced and variable glycosylated forms on a wide variety of cell types including mature T-cells, B-cells, medullary THYMOCYTES; GRANULOCYTES; MACROPHAGES; erythrocytes, and fibroblasts. Their interaction with HYALURONIC ACID mediates binding of lymphocytes to high endothelial VENULES.
| Descriptor ID |
D018960
|
| MeSH Number(s) |
D09.698.735.200.625 D12.776.395.550.200.625.144 D12.776.395.650.750.281 D12.776.543.550.200.625.144 D12.776.543.750.705.877.144 D23.050.301.350.625.144
|
| Concept/Terms |
Hyaluronan Receptors- Hyaluronan Receptors
- Hyaluronic Acid Binding Protein
- Hyaluronan-Binding Protein
- Hyaluronan Binding Protein
- CD44 Antigen
- Antigen, CD44
- Receptors, Hyaluronan
- Antigens, CD44
- Hyaluronan Receptor
- Receptor, Hyaluronan
- Chondroitin Sulfate Proteoglycan 8
- CD44 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Hyaluronan Receptors".
Below are MeSH descriptors whose meaning is more specific than "Hyaluronan Receptors".
This graph shows the total number of publications written about "Hyaluronan Receptors" by people in this website by year, and whether "Hyaluronan Receptors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2021 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyaluronan Receptors" by people in Profiles.
-
Basta MD, Paulson H, Walker JL. The local wound environment is a key determinant of the outcome of TGFß signaling on the fibrotic response of CD44+ leader cells in an ex vivo post-cataract-surgery model. Exp Eye Res. 2021 12; 213:108829.
-
Thangavel K, Lakshmikuttyamma A, Thangavel C, Shoyele SA. CD44-targeted, indocyanine green-paclitaxel-loaded human serum albumin nanoparticles for potential image-guided drug delivery. Colloids Surf B Biointerfaces. 2022 Jan; 209(Pt 1):112162.
-
Liu X, Adorno-Cruz V, Chang YF, Jia Y, Kawaguchi M, Dashzeveg NK, Taftaf R, Ramos EK, Schuster EJ, El-Shennawy L, Patel D, Zhang Y, Cristofanilli M, Liu H. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer. Theranostics. 2021; 11(13):6632-6643.
-
Kang SA, Blache CA, Bajana S, Hasan N, Kamal M, Morita Y, Gupta V, Tsolmon B, Suh KS, Gorenstein DG, Razaq W, Rui H, Tanaka T. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016 05 24; 16:331.
-
Grau JJ, Mesía R, de la Iglesia-Vicente M, Williams ES, Taberna M, Caballero M, Larque AB, de la Oliva J, Cordón-Cardo C, Domingo-Domenech J. Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma. Oncology. 2016; 90(5):267-72.
-
Dang H, Steinway SN, Ding W, Rountree CB. Induction of tumor initiation is dependent on CD44s in c-Met? hepatocellular carcinoma. BMC Cancer. 2015 Mar 21; 15:161.
-
Ghosh B, Li Y, Thayer SA. Inhibition of the plasma membrane Ca2+ pump by CD44 receptor activation of tyrosine kinases increases the action potential afterhyperpolarization in sensory neurons. J Neurosci. 2011 Feb 16; 31(7):2361-70.
-
Yu M, Smolen GA, Zhang J, Wittner B, Schott BJ, Brachtel E, Ramaswamy S, Maheswaran S, Haber DA. A developmentally regulated inducer of EMT, LBX1, contributes to breast cancer progression. Genes Dev. 2009 Aug 01; 23(15):1737-42.